EP3464309
FOSFÓRAMÍÐAT-KIRNISLEIFA-AFLEIÐUR SEM KRABBAMEINSLYF
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
31.5.2017EP published:
10.6.2020EP application number:
17728596.2
EP translation filed:
24.6.2020Grant published:
15.7.2020EPO information:
European Patent Register
Max expiry date:
30.5.2037Expiry date:
30.5.2024
Title:
PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS
Timeline
Today
31.5.2017EP application
10.6.2020EP Publication
24.6.2020Translation submitted
15.7.2020Registration published
30.5.2024Expires
Owner
Name:
NuCana plcAddress:
3 Lochside Way, Edinburgh EH12 9DT, GB
Inventor
Name:
GRIFFITH, HughAddress:
Edinburgh EH12 9DT, GB
Name:
SERPI, MichaelaAddress:
Cardiff South Glamorgan CF10 3NB, GB
Name:
SLUSARCZYK, MagdalenaAddress:
Cardiff South Glamorgan CF10 3NB, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201609601Date:
1.6.2016Country:
GB
Classification
Categories:
C07H 19/173, A61K 31/7076, C07H 19/207, A61P 35/00, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 5.5.2021
Expires: 30.5.2022
Payer: Patice ehf.
Number: 6
Paid: 2.5.2022
Expires: 30.5.2023
Payer: Patice ehf.
Number: 7
Paid: 3.5.2023
Expires: 30.5.2024
Payer: Árnason Faktor ehf.